Compare POLY MEDICURE with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

POLY MEDICURE vs KMS MEDISURGI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    POLY MEDICURE KMS MEDISURGI POLY MEDICURE/
KMS MEDISURGI
 
P/E (TTM) x 58.8 - - View Chart
P/BV x 8.9 1.8 507.3% View Chart
Dividend Yield % 0.3 0.1 191.6%  

Financials

 POLY MEDICURE   KMS MEDISURGI
EQUITY SHARE DATA
    POLY MEDICURE
Mar-21
KMS MEDISURGI
Mar-21
POLY MEDICURE/
KMS MEDISURGI
5-Yr Chart
Click to enlarge
High Rs91340 2,257.1%   
Low Rs20733 627.9%   
Sales per share (Unadj.) Rs82.022.8 360.4%  
Earnings per share (Unadj.) Rs13.80.4 3,709.4%  
Cash flow per share (Unadj.) Rs18.81.4 1,365.2%  
Dividends per share (Unadj.) Rs2.500.05 5,000.0%  
Avg Dividend yield %0.40.1 327.8%  
Book value per share (Unadj.) Rs100.619.6 514.5%  
Shares outstanding (eoy) m95.883.30 2,905.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.81.6 423.1%   
Avg P/E ratio x40.598.5 41.1%  
P/CF ratio (eoy) x29.826.7 111.8%  
Price / Book Value ratio x5.61.9 296.4%  
Dividend payout %18.113.4 134.8%   
Avg Mkt Cap Rs m53,703121 44,311.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,4187 20,724.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,86575 10,472.3%  
Other income Rs m1841 19,182.3%   
Total revenues Rs m8,04976 10,582.2%   
Gross profit Rs m2,1655 42,869.5%  
Depreciation Rs m4753 14,357.1%   
Interest Rs m1060 32,245.5%   
Profit before tax Rs m1,7672 74,575.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4421 38,754.4%   
Profit after tax Rs m1,3261 107,775.6%  
Gross profit margin %27.56.7 409.1%  
Effective tax rate %25.048.3 51.8%   
Net profit margin %16.91.6 1,030.0%  
BALANCE SHEET DATA
Current assets Rs m7,49577 9,760.3%   
Current liabilities Rs m2,15119 11,595.9%   
Net working cap to sales %67.977.6 87.6%  
Current ratio x3.54.1 84.2%  
Inventory Days Days1950 250,980.0%  
Debtors Days Days726305,066,436 0.0%  
Net fixed assets Rs m5,17917 31,296.0%   
Share capital Rs m47933 1,452.7%   
"Free" reserves Rs m9,16832 29,069.2%   
Net worth Rs m9,64865 14,948.6%   
Long term debt Rs m63310 6,167.3%   
Total assets Rs m12,67493 13,577.3%  
Interest coverage x17.68.2 214.4%   
Debt to equity ratio x0.10.2 41.3%  
Sales to assets ratio x0.60.8 77.1%   
Return on assets %11.31.7 675.5%  
Return on equity %13.71.9 721.6%  
Return on capital %18.23.6 503.8%  
Exports to sales %61.30-   
Imports to sales %26.923.6 114.0%   
Exports (fob) Rs m4,818NA-   
Imports (cif) Rs m2,11618 11,943.5%   
Fx inflow Rs m4,8180-   
Fx outflow Rs m2,11619 11,281.3%   
Net fx Rs m2,702-19 -14,400.3%   
CASH FLOW
From Operations Rs m1,1875 22,360.1%  
From Investments Rs m-4,356-1 418,829.8%  
From Financial Activity Rs m3,169-1 -301,856.2%  
Net Cashflow Rs m13 30.2%  

Share Holding

Indian Promoters % 44.5 74.4 59.8%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 17.1 0.0 -  
FIIs % 14.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 55.2 25.6 215.9%  
Shareholders   35,166 54 65,122.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

POLY MEDICURE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of POLY MEDICURE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of POLY MEDICURE. Also includes updates on the valuation of POLY MEDICURE.

POLY MEDICURE Announces Quarterly Results (1QFY22); Net Profit Up 42.0% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, POLY MEDICURE has posted a net profit of Rs 369 m (up 42.0% YoY). Sales on the other hand came in at Rs 2 bn (up 24.4% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.

ITC to Coal India: Are these the Best Dividend Stocks You can Count on? (Views On News)

Jan 25, 2022

A list of companies that have paid dividends regularly for years, creating value for shareholders.

JLR, Corus, Tetley - Was Ratan Tata's Go Global Strategy Right Afterall? (Views On News)

Jan 20, 2022

Ratan Tata took the lead in global acquisitions and changed the mindset of India's business leaders. Was he successful after all?

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

POLY MEDICURE SHARE PRICE


Jan 25, 2022 (Close)

TRACK POLY MEDICURE

  • Track your investment in POLY MEDICURE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

POLY MEDICURE - RAAJ MEDISAFE COMPARISON

COMPARE POLY MEDICURE WITH

MARKET STATS